Global

UK, Brazilian ads take top honors at Globals

UK, Brazilian ads take top honors at Globals

An organ-donation campaign with a Brazilian football tie-in, and a UK managed-access company's series of documentary films, took top honors.

AstraZeneca consolidates R&D, moves US commercial roles

AstraZeneca consolidates R&D, moves US commercial roles

By

AstraZeneca is cutting 650 jobs in the US, "primarily in R&D," and consolidating its R&D operations at three "strategic R&D centers" in "bioscience clusters," academic and industrial beehives where the company can tap into concentrations of talent and infrastructure.

Pharma's iPad, emerging-markets strategies to get 2nd look in 2013, agency execs predict

From tech shifts to talent, and from emerging markets to engaging with social media, agency execs offer their predictions for what the New Year will bring.

Past the patent cliff, pharmas are set for rebound in NMEs, says IMS

By

Industry pipelines might not be brimful of blockbusters, but after years of meager output, biopharma firms are poised to tap a cornucopia of innovative treatments as thirty-something New Molecular Entities launch each year through 2016.

McCann renames global health network in bid to broaden beyond drug advertising

McCann renames global health network in bid to broaden beyond drug advertising

By

McCann Healthcare Worldwide changed its name to McCann Health, and five of its six US agencies rebranded to align more closely with their parent, the network said today.

Pfizer, Crestor tops for global promotional spend in 2011

Pfizer, Crestor tops for global promotional spend in 2011

By

Total global pharma promotional spending fell 3.4% to $92.2 billion in 2011, according to Cegedim Strategic Data, led by a 4.7% decline in detailing spend.

Takeda looks to build vaccines business

By

Takeda is getting into vaccines with the launch of a dedicated global division that will make use of Nycomed A/S's business infrastructure in Europe and emerging markets.

Company news: FDA, Ranbaxy, Daiichi Sankyo and ImpactRx

The FDA issued Driving Innovation, a blueprint for fostering American biomedical innovation, reiterating a prior commitment to reform regulation and announcing policies aimed at facilitating personalized medicine.

UK PR pitch could portend US acquisitions for AstraZeneca

By

AstraZeneca is reviewing its UK financial PR business amid media speculation on a possible acquisitions run in the US, reports our sister publication, PRWeek UK.

Roche-sponsored blog pushes HPV test in UK

Roche-sponsored blog pushes HPV test in UK

By

Roche, which is launching an HPV test, is sponsoring a blog by a UK healthcare reporter chronicling the process of getting a pap smear.

Global healthcare pros prefer live reps, survey finds

By

For all the talk of e-detailing and digitizing the sales force, a plurality of international healthcare professionals would rather get info about new treatments from flesh-and-blood reps than through any other channel, a survey found.

Teva, P&G partner to form global OTC behemoth

By

Teva is partnering with Procter & Gamble in an OTC drug marketing joint venture that will boast annual sales of more than $1 billion -- and which could ultimately be worth four times that, the companies say.

Pharma deals with disruptions at Egypt offices

By

Staffers have been sent home and security has been bolstered at pharma offices located in Egypt's capital city, amid protests in Tahrir Square that have turned violent in recent days.

Merck, GSK expand sales forces in China

Merck, GSK expand sales forces in China

By

Merck and GSK are both increasing the number of sales reps operating in China, according to separate presentations given by the two companies. In both cases, added reps in emerging markets are helping to offset significant reductions in US sales forces, company executives said.

Stronger growth for global pharma in 2011, says IMS

By

Global pharma market growth will pick up steam in 2011, with growth of 5%-7% to $880 billion, over 4%-5% growth in 2010, according to IMS Health.

Sanofi-Aventis to reassign global media duties

By

Sanofi-Aventis put its global media buying and planning account up for review, a spokesperson for the company confirmed today.

Global drug sales to grow 5%-8% through 2014 despite patent losses, says IMS

Global drug sales to grow 5%-8% through 2014 despite patent losses, says IMS

By

Global sales of pharmaceuticals will grow at a rate of 5%-8% annually over the next five years, IMS Health forecasts -- even as products with sales of more than $142 billion lose patent protection in top markets, reducing drug spending by $80-$100 billion.

AIA launches website for global patient offerings

By

Atkins International Associates (AIA) launched a multifaceted life sciences website for marketers communicating to patients across the globe.

Email Newsletters

MM&M Future Leaders


Register now

Early bird $1,950 before 31 October 2014

*Group discounts available on request 

MM&M EBOOK: PATIENT ACCESS

Patient access to pharmaceuticals is a tale of two worlds—affordability has improved for the majority, while the minority is hampered by cost, distribution and red tape. To provide marketers with a well-rounded perspective, MM&M presents this e-book chock full of key insights. Click here to access it.